Intrinsic Value of S&P & Nasdaq Contact Us

Greenrose Acquisition Corp. GNRSW OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
36/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Greenrose Acquisition Corp. (GNRSW) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 33/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
36/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
~
PAST
50/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — GNRSW

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $0.00 $0.00 $-7.00 -
2020 $3.46 $28.38M $714.63K 2.5%
2021 $1.12 $25.4M $17.93M 70.6%
2022 $0.00 $0.00 $0.00 -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message